Detalles de la búsqueda
1.
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival.
Haematologica
; 109(1): 220-230, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439344
2.
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
J Cancer Res Clin Oncol
; 147(1): 205-212, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683487
Resultados
1 -
2
de 2
1
Próxima >
>>